Protein Sequencing Market Size & Growth Forecast 2027–2036, By Segments (Product & Service, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Protein Sequencing Market size was more than USD 1.5 billion in 2026 and is set to grow at a 3.52% CAGR between 2027 and 2036, surpassing USD 2.12 billion by 2036. The industry revenue for 2027 is assessed at USD 1.54 billion.
Get more details on this report
Request Free Sample ReportProtein Sequencing Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to strong life sciences ecosystem, advanced proteomics infrastructure, and extensive use of high-precision sequencing in research, clinical, and biopharmaceutical applications.
- Asia Pacific grows at 4.33% CAGR, driven by rising biotech investment, expanding pharmaceutical research capacity, and increasing adoption of advanced proteomics tools in drug discovery programs.
Segment Momentum
- Protein Sequencing Products held a 76.86% share in 2026 as laboratories rely on in-house instruments, reagents, and consumables to maintain direct control over sequencing workflows, sample preparation, and result validation.
- Pharmaceutical & Biotechnology Companies are expanding fastest as demand grows for precise protein characterization to support drug discovery, therapeutic validation, and product development with commercially focused analytical workflows.
Market Expansion Drivers
- Advancements in mass spectrometry improving accuracy and efficiency of protein sequencing workflows.
- Growing target-based drug development increasing sequencing applications in biopharmaceutical research.
- Expanding biomarker discovery programs supporting personalized medicine and clinical proteomics adoption.
Leading Market Participants
- Leading companies in the protein sequencing market include Thermo Fisher Scientific Inc. (United States), Agilent Technologies, Inc. (United States), Shimadzu Corporation (Japan), Charles River Laboratories International, Inc. (United States), Rapid Novor, Inc. (Canada), Proteome Factory AG (Germany), Alphalyse A/S (Denmark), Bioinformatics Solutions Inc. (Canada), Creative Proteomics (United States), Selvita S.A. (Poland).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.5 billion
- 2027 Estimated Market Size: USD 1.54 billion.
- Projected Market Size: USD 2.12 billion by 2036
- Growth Forecast: 3.52% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Protein Sequencing Products (Product & Service) | Academic Institutes & Research Centers (End Use) | Bio-therapeutics (Application)
- Emerging Opportunity Segment: Protein Sequencing Services (Product & Service) | Pharmaceutical & Biotechnology Companies (End Use) | Genetic Engineering (Application)
Market Growth Drivers and Industry Trends
Advancements in mass spectrometry improving accuracy and efficiency of protein sequencing workflows
Technological progress in mass spectrometry is contributing to the protein sequencing market by improving the ability of researchers to identify, characterize, and analyze proteins with greater analytical precision. Enhanced instrument sensitivity, resolution, and data-processing capabilities enable laboratories to examine complex protein samples and obtain more detailed information about amino acid sequences, modifications, and molecular characteristics. Improvements in sample preparation and computational interpretation further streamline sequencing workflows, allowing researchers to process complex biological datasets more efficiently. These developments are particularly valuable in proteomics research, where accurate protein characterization is essential for understanding biological mechanisms and differentiating molecular changes associated with disease.
Growing target-based drug development increasing sequencing applications in biopharmaceutical research
Expansion of target-based drug development is broadening demand for protein sequencing technologies as researchers require detailed characterization of proteins involved in disease pathways and therapeutic mechanisms. The protein sequencing market benefits from the need to identify molecular targets, understand protein structure and function, and evaluate changes associated with therapeutic intervention during drug discovery and development. Sequencing information can help researchers characterize candidate targets and investigate protein variants or modifications that may influence biological activity and treatment response. As biopharmaceutical research increasingly relies on molecular-level understanding of disease mechanisms, protein analysis and sequencing are becoming integrated into a wider range of discovery and validation workflows.
Expanding biomarker discovery programs supporting personalized medicine and clinical proteomics adoption
Expansion of biomarker discovery initiatives is supporting the protein sequencing market as researchers seek molecular indicators that can improve disease detection, patient stratification, and treatment selection. Protein-level analysis can reveal changes in biological pathways and molecular profiles that may serve as potential biomarkers for different diseases or therapeutic responses. These capabilities are increasingly relevant to personalized medicine, where understanding differences between patient populations can support more targeted clinical decision-making. Clinical proteomics programs also require detailed characterization of proteins and their modifications to investigate disease mechanisms and identify clinically meaningful molecular signatures, encouraging broader use of sequencing technologies within translational and diagnostic research.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Advancements in mass spectrometry improving accuracy and efficiency of protein sequencing workflows | 1.90% | High | North America, Europe | High | Mid Term |
| Growing target-based drug development increasing sequencing applications in biopharmaceutical research | 1.60% | High | North America, Asia Pacific | High | Near Term |
| Expanding biomarker discovery programs supporting personalized medicine and clinical proteomics adoption | 1.20% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the protein sequencing market in 2026, underpinned by sophisticated life sciences infrastructure, strong proteomics research capabilities, and substantial activity in pharmaceutical development and biotechnology. Demand is supported by applications in biomarker discovery, disease research, precision medicine, and advanced drug development, where detailed characterization of proteins is increasingly important. The region's established research institutions, advanced laboratory capabilities, and continued investment in molecular analysis technologies are also supporting the integration of protein sequencing into broader biomedical research workflows.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, with expanding biotechnology and pharmaceutical activity creating greater demand for advanced proteomic research tools. Increasing investment in healthcare research infrastructure, precision medicine, drug discovery, and molecular diagnostics is encouraging broader adoption of protein sequencing technologies. The development of research capabilities and modernization of laboratories across emerging markets are further widening the addressable application base, while growing interest in complex biological characterization is supporting sustained regional momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Biopharma Analytical ExcellenceGermany prioritizes protein sequencing technologies that strengthen pharmaceutical research, biologics development, and analytical laboratory capabilities. Organizations in Germany increasingly invest in high-precision proteomics workflows that improve biomarker identification and quality assessment.
France 🇫🇷
Translational Research CapabilityFrance applies protein sequencing technologies across academic research, clinical laboratories, and pharmaceutical innovation. Institutions in France increasingly emphasize integrated proteomics workflows that improve biological understanding and accelerate translational research initiatives.
Italy 🇮🇹
Academic Proteomics AdvancementItaly continues strengthening protein sequencing capabilities through collaborations between research institutes, universities, and healthcare laboratories. Organizations across Italy are expanding advanced proteomics applications to improve molecular research, biomarker studies, and pharmaceutical development activities.
Japan 🇯🇵
Clinical Proteomics DevelopmentJapan continues expanding protein sequencing applications across biomedical research and translational medicine. Academic institutes and healthcare organizations in Japan are strengthening proteomics capabilities to support biomarker discovery, disease research, and next-generation therapeutic development.
South Korea 🇰🇷
Biotechnology Research ExpansionSouth Korea is increasing adoption of protein sequencing technologies to strengthen biotechnology innovation and pharmaceutical research. Research organizations in South Korea are expanding proteomics capabilities through advanced analytical platforms that support drug development and molecular characterization.
United States 🇺🇸
Advanced Proteomics ResearchThe U.S. protein sequencing market is supported by strong investment in life sciences research, precision medicine, and biopharmaceutical development. Research institutions and biotechnology companies across the U.S. continue adopting advanced sequencing platforms to accelerate protein characterization and therapeutic discovery.
Segment Leadership and Growth Trends
Protein Sequencing Market Share (%), by Product & Service, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct & Service Segment Analysis: Protein Sequencing Products (Largest Segment) vs Protein Sequencing Services (Fastest-Growing Segment)
The protein sequencing products segment held the largest share of the protein sequencing market at 76.86% in 2026, supported by the essential role of sequencing instruments, reagents, consumables, and related products in enabling accurate characterization of protein structures and compositions. Continued advances in sequencing technologies are improving analytical capabilities and supporting their use across proteomics research, biomarker discovery, and molecular investigations. The growing need for precise protein-level information is also encouraging research organizations and laboratories to adopt increasingly sophisticated sequencing platforms and supporting products, reinforcing the segment's established position.
Protein sequencing services represent the fastest-growing segment, benefiting from increasing demand for specialized sequencing capabilities without requiring end users to establish and maintain extensive in-house infrastructure. Outsourced services can provide access to specialized expertise, advanced analytical workflows, and sophisticated sequencing technologies, making them attractive to organizations seeking efficient and flexible research solutions. Rising proteomics activity and the expanding complexity of protein characterization are further supporting demand for external service providers, particularly where researchers require specialized analytical support for discovery and validation activities.
End Use Segment Analysis: Academic Institutes & Research Centers (Largest Segment) vs Pharmaceutical & Biotechnology Companies (Fastest-Growing Segment)
Academic institutes & research centers accounted for a 51.94% share of the protein sequencing market in 2026, reflecting their extensive involvement in fundamental proteomics research, molecular biology, disease investigation, and protein characterization. These institutions rely on sequencing technologies to generate detailed biological insights and support experimental studies spanning multiple areas of life sciences. Increasing emphasis on understanding protein function and molecular mechanisms is strengthening the role of sequencing within research programs, while continued development of advanced analytical techniques is expanding the range of applications available to academic and research users.
In the protein sequencing market, pharmaceutical & biotechnology companies are the fastest-growing end-use segment as protein-level analysis becomes increasingly important across drug discovery, therapeutic development, biomarker research, and biological characterization. These organizations require detailed information about proteins to support the evaluation of biological targets and the development of innovative therapies. The expanding complexity of biologic research and growing reliance on precision analytical techniques are creating stronger demand for sequencing capabilities within industrial research environments. As pharmaceutical and biotechnology pipelines become more dependent on advanced molecular insights, adoption among these users is gaining momentum.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product & Service | Protein Sequencing Products, Protein Sequencing Services | Protein Sequencing Products | Protein Sequencing Services |
| End Use | Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Others | Academic Institutes & Research Centers | Pharmaceutical & Biotechnology Companies |
| Application | Bio-therapeutics, Genetic Engineering, Others | Bio-therapeutics | Genetic Engineering |
Competitive Landscape and Market Positioning
Major players in the protein sequencing market:
1. Thermo Fisher Scientific Inc. (United States)
2. Agilent Technologies Inc. (United States)
3. Shimadzu Corporation (Japan)
4. Charles River Laboratories International Inc. (United States)
5. Rapid Novor Inc. (Canada)
6. Proteome Factory AG (Germany)
7. Alphalyse A/S (Denmark)
8. Bioinformatics Solutions Inc. (Canada)
9. Creative Proteomics (United States)
10. Selvita S.A. (Poland)
The protein sequencing market is advancing due to increasing demand for proteomics research and biomedical innovation. The protein sequencing market is witnessing technological improvements in sequencing accuracy and speed. Continuous research collaboration is strengthening life sciences and drug discovery capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| Shimadzu Corporation (Japan) | |||||||
| Charles River Laboratories International Inc. (United States) | |||||||
| Rapid Novor Inc. (Canada) | |||||||
| Proteome Factory AG (Germany) | |||||||
| Alphalyse A/S (Denmark) | |||||||
| Bioinformatics Solutions Inc. (Canada) | |||||||
| Creative Proteomics (United States) | |||||||
| Selvita S.A. (Poland). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Promise Bio | May-26 | Promise Bio deployed an AI-driven platform integrating proteomics and multi-omics data with a focus on post-translational modifications. The platform optimizes biomarker identification and disease pathway mapping, strengthening commercial capabilities for advanced protein analysis and precision sequencing applications. |
| Portal Biotech | Jul-25 | Portal Biotech secured $35 million in Series A financing to accelerate the development and commercialization of its full-length single-molecule protein sequencer. The funding supports the scaling of AI-enabled technology designed to expand accessible applications within the protein sequencing market. |
| Basecamp Research | Jun-25 | Basecamp Research expanded its biological sequence data assets through the launch of BaseData. By providing a comprehensive repository of protein diversity data exceeding public databases, the initiative strengthens underlying data infrastructure required for AI-driven biological analysis and advanced protein research workflows. |
| Bruker | May-25 | Bruker launched the timsOmni mass spectrometer, introducing advanced depth and speed for functional proteoform sequencing. The system improves the identification and localization of post-translational modifications, enhancing analytical throughput and resolution for complex protein characterization workflows. |
| Thermo Fisher Scientific, Inc. | Oct-23 | Thermo Fisher Scientific, Inc. acquired Olink to enhance its protein sequencing and biomarker discovery capabilities. The transaction integrates Olink's Proximity Extension Assay technology and a library of over 5,300 validated protein biomarkers, accelerating advanced capabilities in life sciences research and precision medicine workflows. |
| Agilent Technologies Inc. | Jun-23 | Agilent Technologies Inc. launched the 6495D LC/TQ and Revident LC/Q-TOF liquid chromatography-mass spectrometry systems to enhance high-sensitivity targeted and untargeted protein sequencing. Supported by MassHunter Explorer and ChemVista software, the systems improve processing efficiency and productivity for high-volume proteomics research. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Protein Sequencing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sequencing Technology | Edman Degradation, Mass Spectrometry-Based Sequencing, De Novo Sequencing, Next-Generation Protein Sequencing |
| Protein Type | Single Proteins, Protein Complexes, Membrane Proteins, Post-Translationally Modified Proteins |
| Sample Source | Cell & Tissue Samples, Biological Fluids, Recombinant Proteins, Microbial Samples, Clinical Samples |
Protein Sequencing Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Protein Sequencing Technology Adoption Roadmap |
|
| Proteomics Research Application Opportunity Analysis |
|
| Biopharma Discovery Impact Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow large is the protein sequencing market?
How will the protein sequencing industry grow in terms of size and CAGR by 2036?
How are advances in mass spectrometry influencing demand in the protein sequencing market?
Why is personalized medicine expanding commercial opportunities in the protein sequencing market?
Why do Protein Sequencing Products lead the protein sequencing market?
Why are Pharmaceutical & Biotechnology Companies the fastest-growing end users in the protein sequencing market?
Why is North America the leading market for protein sequencing?
What is supporting Asia Pacific growth in protein sequencing?
Who holds a significant market share in the protein sequencing landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization